Niagen Bioscience, Inc. Common Stock

NAGE XNAS • MEDICINAL CHEMICALS & BOTANICAL PRODUCTS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

280M

Short interest (May 15)

6.3%

Borrow Fee

0.40%

↑ 1.5%

Available Shares

↓ 11.5%

Price Chart

Company Overview

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Company Info

Exchange: NASDAQ

Industry: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS

CIK: 0001386570

Asset Type: CS

Market Data

Market Cap: $281,940,917

Employees: 117

Status: Active

Short Interest

Current Borrow Fee 0.40%

Range: 0.40% - 0.40%

Available Shares 6M

Range: 6.3M - 6.3M

Recent Changes

Fee Change: ↓ 6.0%

Available Change: ↑ 0.8%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime